{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:10:05Z","timestamp":1784225405636,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Congenital cytomegalovirus infection is one of the leading causes of nongenetic sensorineural hearing loss. The aim of our retrospective cohort study was to describe the changes in hearing in relation to antiviral therapy and the trend in viremia and viruria in children with congenital cytomegalovirus infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In the present study, data were collected from infants treated with valganciclovir for 6 weeks or 6 months or untreated, seen between 2000 and 2021 at the Infectious Diseases Unit, Meyer Children\u2019s University Hospital, Florence, Italy. Hearing deterioration was studied using Kaplan-Meier survival curves and risk factors for the outcome \u201cdeterioration\u201d with Cox analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Ninety-eight children were enrolled. Three children developed late hearing loss (2 children treated with valganciclovir for 6 weeks and 1 untreated). Kaplan-Meier survival curves of children treated for 6 weeks and 6 months overlapped until 36 months of life, after then 2 children of the 6-week group showed a worsening of hearing function (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.609). Cox analysis did not show a significant impact of analyzed variables (group of therapy, viruria and viremia) on the outcome. The resolution of detectable viruria and viremia was significantly faster in the 6-month group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.011, &lt;0.001, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study is the first that reports audiological characteristics at follow-up after 24 months of life in treated and untreated children with congenital cytomegalovirus infection. In our population, 6 months therapy may prevent the development of late hearing loss, although the different regimens did not differ in influencing the progression of congenital deafness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000003727","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:03:39Z","timestamp":1670411019000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Hearing Outcome and Virologic Characteristics of Children With Congenital Cytomegalovirus Infection in Relation to Antiviral Therapy: A Retrospective Cohort Study"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0048-3933","authenticated-orcid":false,"given":"Elisabetta","family":"Venturini","sequence":"first","affiliation":[{"name":"Infectious Disease Unit, Meyer Children\u2019s Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Impagnatiello","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Meyer Children\u2019s Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chiappini","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Meyer Children\u2019s Hospital, Florence, Italy"},{"name":"Department of Health Sciences, University of Florence, Florence, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7912-3366","authenticated-orcid":false,"given":"Luisa","family":"Galli","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Meyer Children\u2019s Hospital, Florence, Italy"},{"name":"Department of Health Sciences, University of Florence, Florence, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,11]]},"reference":[{"key":"R1-20260716","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/jac\/dkp083","article-title":"Treatment of congenital Cytomegalovirus infection: implications for future therapeutic strategies.","volume":"63","author":"Nassetta","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R2-20260716","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijporl.2010.12.008","article-title":"Hearing status in children with congenital cytomegalovirus: up-to-6-years audiological follow-up.","volume":"75","author":"Royackers","year":"2011","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R3-20260716","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease.","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20260716","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00431-010-1176-9","article-title":"Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.","volume":"169","author":"Amir","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R5-20260716","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/tropej\/fmq050","article-title":"Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.","volume":"57","author":"Yilmaz Ciftdogan","year":"2011","journal-title":"J Trop Pediatr"},{"key":"R6-20260716","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/ijms20061388","article-title":"Efficacy of valganciclovir treatment depends on the severity of hearing dysfunction in symptomatic infants with congenital cytomegalovirus infection.","volume":"20","author":"Ohyama","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R7-20260716","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0009922813510204","article-title":"Treatment of late-onset hearing loss in infants with congenital cytomegalovirus infection.","volume":"53","author":"Amir","year":"2014","journal-title":"Clin Pediatr (Phila)"},{"key":"R8-20260716","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R9-20260716","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","article-title":"Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment.","volume":"43","author":"Marsico","year":"2017","journal-title":"Ital J Pediatr"},{"key":"R10-20260716","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2012.06.001","article-title":"Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period.","volume":"55","author":"del Rosal","year":"2012","journal-title":"J Clin Virol"},{"key":"R11-20260716","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.braindev.2015.08.003","article-title":"Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment.","volume":"38","author":"Nishida","year":"2016","journal-title":"Brain Dev"},{"key":"R12-20260716","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/microorganisms8101516","article-title":"Congenital cytomegalovirus infection: update on diagnosis and treatment.","volume":"8","author":"Chiopris","year":"2020","journal-title":"Microorganisms"},{"key":"R14-20260716","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijporl.2018.12.027","article-title":"Long-Term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir.","volume":"118","author":"McCrary","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R15-20260716","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14639\/0392-100X-2020","article-title":"Hearing loss in children with congenital cytomegalovirus infection: an 11-year retrospective study based on laboratory database of a tertiary paediatric hospital.","volume":"39","author":"Palma","year":"2019","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R16-20260716","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1542\/peds.2005-0629","article-title":"Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns.","volume":"117","author":"Lanari","year":"2006","journal-title":"Pediatrics"},{"key":"R17-20260716","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/INF.0b013e3181979a27","article-title":"Cytomegalovirus blood viral load and hearing loss in young children with congenital infection.","volume":"28","author":"Ross","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20260716","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00006454-200006000-00003","article-title":"Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group.","volume":"19","author":"Noyola","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20260716","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jpeds.2005.01.059","article-title":"Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss.","volume":"146","author":"Boppana","year":"2005","journal-title":"J Pediatr"},{"key":"R20-20260716","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/infdis\/jiu627","article-title":"High Cytomegalovirus (CMV) DNAemia predicts CMV sequelae in asymptomatic congenitally infected newborns born to women with primary infection during pregnancy.","volume":"212","author":"Forner","year":"2015","journal-title":"J Infect Dis"},{"key":"R21-20260716","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/infdis\/jiy695","article-title":"Blood viral load in symptomatic congenital cytomegalovirus infection.","volume":"219","author":"Marsico","year":"2019","journal-title":"J Infect Dis"},{"key":"R22-20260716","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.mlg.0000154722.55044.fc","article-title":"Cytomegalovirus in the perilymphatic fluid.","volume":"115","author":"Bauer","year":"2005","journal-title":"Laryngoscope"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:02:28Z","timestamp":1784224948000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,11]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003727","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,11]]}}}